Kester-backed Frontier sells business to HIG-backed Vernacare

HIG acquired Vernacare from Palatine Private Equity in February 2020. At the time, HIG was investing from Growth Buyout Equity Fund III, which closed on $970m in October 2018 and was 3% deployed as of September 2019.

Kester acquired Frontier in 2013. It has grown the company's revenues, EBITDA and head count since the initial investment, according to a statement.

Frontier's core division, Frontier Therapeutics, a provider of skin and wound care products comprising the Repose, Toto and Dermisplus brands, will continue to operate as usual under the direction of the existing management team led by Simon Jackson, backed by Kester.

Company
Frontier Medical is headquartered in Blackwood and was founded in 1966. The acquired division includes the brands Sharpsafe, Clinisafe and Exchange. The exited businesses provide a range of sharps and clinical waste disposal products and services.

People
Kester Capital – Cameron Crockett (managing partner).
Frontier Medical – Simon Jackson (CEO).

Advisers
Vendor – Deloitte (corporate finance); Travers Smith (legal); Grant Thornton (financial due diligence); CiL (commercial due diligence).
Company – TLT (legal).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Exits
• Portfolio management
• UK / Ireland
• Healthcare
• United Kingdom
• Partial sale
• Build-up
• Buy-and-build